Health care and prevention thanks to automated urinalysis and artificial intelligence. Medipee GmbH receives further capital for the development of its platform technology.
The Moers-based start-up Medipee has been able to win over the companies Geberit and WBG as investors as part of a financing round. Other investors from the digital healthcare industry also participated in the so-called A-round financing. In a second part of the financing round, further investors can now acquire shares in Medipee GmbH.
With the financing, Medipee wants to launch its first product on the market, which will be submitted to the Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) in the second quarter of 2021. Medipee is thus reacting to a new law that guarantees reimbursement for health products by health insurance companies. Medipee’s app-driven platform technology enables touchless urinalysis on the spot.
Co-founder and Managing Director of Medipee GmbH, Frank Willems, is pleased about the great popularity and interest of industry experts: “For us, the round is a significant milestone on the way to the brand launch of our Medipee platform technology.” The expertise of the two companies helps the start-up in its further development: “All investors are convinced of the potential of our platform – in times of a pandemic more than ever,” Willems continues.
Geberit AG, which operates worldwide, is the European market leader for sanitary products and has extensive know-how in the field of sanitary technology. Together with WBG Holding GmbH, as the operator of several nursing homes in Germany, the two companies are now investing in the Moers-based start-up. Dr. Christoph Wagner, Managing Director of WBG Pflegeholding, adds: “With Medipee, we have invested in another exciting eHealth start-up. We see the benefits in the entire medical and nursing service area and beyond.”
